LobbyingTrulieve Cannabis lobbying by quarter
Trulieve Cannabis TRLV's latest lobbying report covers Q2 2026, at $300K. The four quarters Q4 2025–Q3 2026 total $825K. Its first report covers Q4 2022; the issues it reports most are Banking.
Trulieve CannabisTRLV
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $825K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $37.5K | 1 |
| Q1 2023 | $37.5K | 1 |
| Q2 2023 | $37.5K | 1 |
| Q3 2023 | $37.5K | 1 |
| Q4 2023 | $37.5K | 1 |
| Q1 2024 | $37.5K | 1 |
| Q2 2024 | $37.5K | 1 |
| Q3 2024 | $37.5K | 1 |
| Q4 2024 | $37.5K | 1 |
| Q1 2025 | $37.5K | 1 |
| Q2 2025 | $225K | 1 |
| Q3 2025 | $275K | 1 |
| Q4 2025 | $225K | 1 |
| Q1 2026 | $300K | 1 |
| Q2 2026 | $300K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Banking$1.7M · 14 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES14 reports
- SENATE14 reports
- Executive Office of the President (EOP)3 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseTrulieve Cannabis | $1.7M | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/06for Q2 | In-house | $300K |
| 04/09for Q1 | In-house | $300K |
| 01/09for Q4 2025 | In-house | $225K |
| 25/10/09for Q3 2025 | In-house | $275K |
| 25/07/18for Q2 2025 | In-house | $225K |
| 25/04/14for Q1 2025 | In-house | $37.5K |
| 25/01/09for Q4 2024 | In-house | $37.5K |
| 24/10/14for Q3 2024 | In-house | $37.5K |
| 24/07/11for Q2 2024 | In-house | $37.5K |
| 24/04/04for Q1 2024 | In-house | $37.5K |
| 24/01/08for Q4 2023 | In-house | $37.5K |
| 23/10/19for Q3 2023 | In-house | $37.5K |
| 23/07/14for Q2 2023 | In-house | $37.5K |
| 23/04/05for Q1 2023 | In-house | $37.5K |
| 23/01/04for Q4 2022 | In-house | $37.5K |